Pathalys Pharma Alternatives & Competitors
12 companies similar to Pathalys Pharma — Our mission is to improve the lives of patients through enhanced therapeutics to...
Companies similar to Pathalys Pharma
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Atea Pharmaceuticals, Inc
Discovery & development of breakthrough therapies for COVID-19 patients and severe viral d...
Boston, United States
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
New York, United States
Angion
Angion is committed to transforming the treatment paradigm for patients suffering from fib...
United States
Rival Readout
Competing with Pathalys Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Ocuphire Pharma
Restoring Vision and Clarity
Farmington Hills, United...
Sling Therapeutics
Focused on late-stage development of an oral small molecule for the treatment of thyroid e...
Ann Arbor, United States
Ocera Therapeutics
Dedicated to Innovation in Liver Disease Treatment, Pioneering Life-Saving Therapeutics fo...
IXALTIS SA
DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS
Toulouse, France
Angitia Biopharmaceuticals
Developing innovative medicines to address serious musculoskeletal diseases
Westlake Village, United...
Reviva Pharmaceuticals
Next Generation Therapeutics to successfully address central nervous system, metabolic and...
Cupertino, United States
Myogen
Advancing cardiovascular health with innovative small molecule therapeutics for unmet medi...
Attralus
Attralus is a biopharmaceutical company creating transformative medicines for patients wit...
Naples, United States
About Pathalys Pharma
Pathalys Pharma, founded in 2021, is a private, late-stage clinical biopharmaceutical company headquartered in the United States. The company's mission is articulated through its slogan: "Our mission is to improve the lives of patients through enhanced therapeutics to advance the management of CKD." This mission unders...
Development of therapeutics for chronic kidney disease, Innovative drug solutions for secondary hyperparathyroidism, Late-stage clinical trials for kidney disease treatments, Regulatory submission and approval process navigation
Patients with chronic kidney disease, Patients undergoing hemodialysis, Healthcare providers specializing in nephrology, Medical research organizations
Biopharmaceutical, Late-stage Clinical Development, Chronic Kidney Disease, End-stage Renal Disease, Secondary Hyperparathyroidism, Therapeutics Development, Unmet Medical Needs, Patient-centric, Pharmaceutical Innovation, Catalys Pacific Partnership, DaVita Collaboration, Parathyroid Disorders, Hyperparathyroidism Treatment, Multi-asset Pharmaceutical
B2B, B2D
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Pathalys Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Pathalys Pharma on 11 Mar 2026. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
